- ►annals.org [PDF] S Sanderson, J Emery, T Baglin, AL Kinmonth - Annals of internal medicine, 2005 - Am Coll Physicians Aspirin is currently the most cost-effective drug for the secondary prevention
of cardiovascular disease, but treatment failures are relatively common. Several
factors have been linked to these re- current vascular events in patients ... Cited by 118 - Related articles - All 6 versions
- ►nih.gov [PDF] GJ Hankey, JW Eikelboom - The Lancet, 2006 - Elsevier Aspirin resistance is the inability of aspirin to reduce platelet production of
thromboxane A 2 and thereby platelet activation and aggregation. Increasing
degrees of aspirin resistance may correlate independently with increasing ... Cited by 292 - Related articles - BL Direct - All 20 versions
- ►onlinejacc.org PJ Mason, AK Jacobs, JE Freedman - Journal of the American College of Cardiology, 2005 - Elsevier Acute coronary syndromes and other manifestations of atherothrombotic disease
are primarily caused by atherosclerotic plaque rupture or fissuring and
subsequent occlusive or subocclusive thrombus formation. Platelets play a ... Cited by 118 - Related articles - BL Direct - All 13 versions
KA Schwartz, DE Schwartz, K Ghosheh, MJ … - The American journal of cardiology, 2005 - Elsevier The mechanism of aspirin resistance remains unclear. Compliance has been
implicated as a possible cause of aspirin resistance. Of 73 patients with
previous myocardial infarctions studied, 21 were classified as “aspirin ... Cited by 110 - Related articles - All 14 versions
K Grundmann, K Jaschonek, B Kleine, J … - Journal of neurology, 2003 - Springer 23% in patients with various cardiovascular and cere- brovascular diseases
[3].Yet,these data also reveal that a significant proportion of the risk of
suffering platelet- dependent vascular events remains.No clear-cut factors ... Cited by 210 - Related articles - BL Direct - All 3 versions
S Fateh-Moghadam, U Plöckinger, N Cabeza, … - Acta Diabetologica, 2005 - Springer Cardiovascular complications are still the leading cause of death among patients
with type 2 diabetes, accounting for 70% of all case fatalities [1, 2]. Numerous
patho- physiological mechanisms have been proposed to explain the ... Cited by 45 - Related articles - All 3 versions
[CITATION] Actualización en Medicina de Familia: Resistencia al ácido acetilsalicílico y sus …
- ►online.no [PDF] K Andersen, M Hurlen, H Arnesen, I Seljeflot - Thrombosis research, 2002 - Elsevier Introduction: The purpose of the present study was to study the concept of
aspirin resistance or non-responsiveness by investigating the response to
long-term aspirin therapy in patients with a former acute myocardial ... Cited by 195 - Related articles - All 8 versions
PY Lee, WH Chen, W Ng, X Cheng, JYY Kwok … - The American journal of medicine, 2005 - Elsevier We studied 468 consecutive stable coronary artery disease patients in a referral
cardiac center who were taking aspirin 80 to 325 mg daily for ≥4 weeks. The
VerifyNow Aspirin (Ultegra RPFA-ASA, Accumetrics Inc, San Diego, Calif) was ... Cited by 110 - Related articles - All 7 versions
